Nichi-Iko Pharmaceutical sells Sagent Pharmaceuticals and Canada-based Omega Laboratories to Ellimist Singapore

On February 28, 2023, Nichi-Iko Pharmaceutical Co., Ltd., a prominent Japanese company specializing in the manufacturing and selling of pharmaceutical and medical products, finalized the sale of all issued and outstanding shares of its wholly owned subsidiaries, Sagent Pharmaceuticals and Omega Laboratories Ltd. This transaction was with Ellimist Singapore Pte. Ltd., and the aggregate purchase price amounted to US$100 million.

Sagent Pharmaceuticals, located in Wyoming, Illinois, USA, is known for its provision of essential specialty injectable products across a diverse range of therapeutic categories. The company's portfolio includes products in various formats such as premix bags, prefilled syringes, single-dose, and pharmacy bulk package vials, catering to the healthcare market's needs.

Omega Laboratories, based in Montreal, Canada, stands as one of the country's largest domestic manufacturers of specialty injectable pharmaceuticals. It offers a broad range of products to healthcare facilities, including both sterile injectable and non-injectable solutions. Omega Laboratories is also engaged in various services like contract manufacturing, licensing, and exporting sterile injectable products.

Merger & Acquisition
Healthcare
$ 134,726,000
Closed
28 February 2023